bioRxiv Science⌕ Search

bioRxiv · 10.1101/358283

Improving peptide-spectrum matching by fragmentation prediction using Hidden Markov Models

Abstract

Tandem mass-spectrometry has become the method of choice for high-throughput, quantitative analysis in proteomics. However, since the link between the peptides and the proteins they originate from is typically broken, identification of the analyzed peptides relies on matching of the fragmentation spectra (MS2) to theoretical spectra of possible candidate peptides, often filtered for precursor ion mass. To this end, peptide-spectrum matching algorithms score the concordance between the experimental and the theoretical spectra of candidate peptides, by evaluating the number (or proportion) of theoretically possible fragment ions observed in the experimental spectra, without any discrimination. However, the assumption that each theoretical fragment is just as likely to be observed is inaccurate. On the contrary, MS2 spectra often have few dominant fragments.\n\nWe propose a novel prediction algorithm based on a hidden Markov model, which allow for the training process to be carried out very efficiently. Using millions of MS/MS spectra generated in our lab, we found an overall good reproducibility across different fragmentation spectra, given the precursor peptide and charge state. This result implies that there is indeed a pattern to fragmentation that justifies using machine learning methods. Furthermore, the overall agreement between spectra of the same peptide at the same charge state serves as an upper limit on how well prediction algorithms can be expected to perform.\n\nWe have investigated the performance of a third order HMM model, trained on several million MS2 spectra, in various ways. Compared to a mock model, in which the fragment ions and their intensities are shuffled, we see a clear difference in prediction accuracy using our model. This result indicates that our model can pick up meaningful patterns, i.e. we can indeed learn the fragmentation process. Secondly, looking at the variability of the prediction performance by varying the train/test data split, in a K-fold cross validation scheme, we observed an overall robust model that performs well independent of the specific peptides that are present in the training data.\n\nLast but not least, we propose that the real value of this model is as a pre-processing step in the peptide identification process, by discerning fragment ions that are unlikely to be intense for a given candidate peptide, rather than using the actual predicted intensities. As such, probabilistic measures of concordance between experimental and theoretical spectra, would leverage better statistics.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kirik, U., Refsgaard, J. C., Juhl Jensen, L.. 2018-06-29. Improving peptide-spectrum matching by fragmentation prediction using Hidden Markov Models. https://doi.org/10.1101/358283

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Accelerating discovery and integration from RNA to Protein with R2T2P

Integrating transcriptomics and proteomics data remains an unmet challenge in the post-genomics era, discouraging researchers from pursuing integrative approaches to molecular biology research. Leveraging the power of translation profiling, we present RNA to Translation to Protein (R2T2P), a computational platform integrating genome-guided transcriptome assembly with identification of translation and proteins, including a tailored differential analysis framework and support for multiple reference transcriptomes. We applied R2T2P to investigate a cellular model of facioscapulohumeral muscular dystrophy (FSHD), where ectopic expression of the DUX4 retrogene in skeletal muscle triggers significant alterations in transcription and RNA metabolism. We uncovered hundreds of uncharacterized, highly overexpressed RNAs, including antisense and alternative transcripts, and quantified their contribution to translatome and proteome. Re-analysis of expression datasets from patient-derived myotubes and muscle biopsies validated this alternative transcriptome in FSHD patients, adding a reservoir of bona-fide novel molecular actors in a rare disease. Available at https://github.com/nfdata-omics/R2T2P/, R2T2P is a flexible and powerful workflow in modern integrative biology.

bioinformatics↗

MorphoANOVA: Dissecting Histology-Gene Expression Relationships in Spatial Transcriptomics

Spatial transcriptomics (ST) measures the expression of hundreds to thousands of genes within tissue architecture, often accompanied by histology images. However, it remains challenging to systematically characterize which genes exhibit associations with tissue morphology, whether these associations vary spatially, and which genes show additional spatial expression patterns beyond those captured by morphology. Here we introduce MorphoANOVA, a gene-wise statistical framework for characterizing morphology--expression relationships across genes measured by ST. Using nested spatially varying coefficient models and sequential ANOVA, MorphoANOVA assesses slide-wide associations with an H\&E-derived morphology feature, location-specific changes in these associations, and additional spatial variation after accounting for the selected feature. The resulting statistics enable gene prioritization and pathway enrichment analysis, while spatial component maps support the interpretation of individual genes. Simulations demonstrate MorphoANOVA's ability to distinguish the modeled components and recover their spatial patterns. Applications to human cortex and breast cancer identify biological programs associated with different morphology--expression patterns and reveal distinct relationships with cell composition. Across three HER2-positive breast cancer patients, invasive-cancer marker genes consistently exhibit stronger evidence of location-specific morphology associations. MorphoANOVA thus provides a framework for systematically interpreting spatial gene-expression patterns in relation to tissue morphology.

bioinformatics↗

Evaluation effects can rival reported concordance gains in cross-cancer survival prediction

Studies of cross-cancer learning for survival prediction from tumour omics have reported concordance gains of 0.020 and 0.045, but how such gains compare with evaluation effects remains unclear. We examined these effects across 13 TCGA cancers (5,761 patients, 1,526 disease-specific deaths), using five repeats of five-fold cross-validation and paired bootstrap intervals. When model selection did not use test data, our borrowing model gained 0.009 (95% interval 0.001 to 0.016) over its target-fitted reference when cancers received equal weight (post hoc). Random-effects pooling gave a gain of 0.002 (-0.002 to 0.006), with most weight assigned to cancers where the model made little use of the pretrained score. Choosing the fusion weight on test splits raised the apparent equal-weight gain to 0.017. We reimplemented a published method, VAECox, which showed no pretraining gain over random initialisation at the last or validation-selected training step. Choosing each network's best test step, as the published code does, raised concordance by 0.03 to 0.05 across the 13-cancer and ten-cancer overall-survival settings, but barely changed the difference between networks. In a constructed post hoc experiment, choosing the best test step only for the pretrained network changed the equal-weight mean difference from -0.004 to +0.045 (+0.035 to +0.054). Across seven multi-omics comparisons, estimates from single five-fold runs differed from their cancer's five-run mean by at least 0.02 in 11% to 42% of runs. Concordance was about 0.02 lower at held-out tissue source sites. Interpreting a reported gain therefore requires each model's selection rule, variation across repeated partitions, the weighting of cancers and the evaluation population.

bioinformatics↗